Port Friedrich K, Pisoni Ronald L, Bragg-Gresham Jennifer L, Satayathum Sudtida S, Young Eric W, Wolfe Robert A, Held Philip J
University Renal Research and Education Association, Kidney Epidemiology and Cost Center, Ann Arbor, MI 48103, USA.
Blood Purif. 2004;22(1):175-80. doi: 10.1159/000074938.
Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS) allow estimation of the percentage of patients outside published hemodialysis guidelines and their associated mortality risk. We estimated the number of life years that could be gained from adherence to four of these guidelines and two other modifiable practices, i.e. dialysis dose, phosphate control, improved anemia, partial correction of serum albumin, reduced interdialytic weight gain and less use of catheters for vascular access. We extrapolated DOPPS data on these practices and guidelines to the US hemodialysis population for a 5-year projected period. Of the practices we examined, the highest relative risk of mortality was associated with having albumin <3.5 g/dl (relative risk=1.38, p<0.0001); 20.5% of the patients in the study fell outside the target range. The adjusted sum of the patient years attributable to all six practice patterns was 143,617; a more conservative estimate, modeling life years potentially gained by bringing half of all patients outside targets within them, is 69,367. The magnitude of potential savings in life years should encourage greater adherence to guidelines and practices that are significantly associated with better survival.
透析预后与实践模式研究(DOPPS)的数据有助于估算未遵循已发布血液透析指南的患者比例及其相关死亡风险。我们估算了遵循其中四条指南以及另外两种可改变的做法(即透析剂量、磷控制、改善贫血、部分纠正血清白蛋白、减少透析间期体重增加以及减少使用导管进行血管通路)所能获得的生命年数。我们将DOPPS关于这些做法和指南的数据外推至美国血液透析人群,预测期为5年。在我们研究的做法中,白蛋白<3.5 g/dl与最高的相对死亡风险相关(相对风险=1.38,p<0.0001);研究中20.5%的患者超出了目标范围。归因于所有六种实践模式的患者年数调整总和为143,617;一个更保守的估计是,假设将所有超出目标范围的患者中的一半调整至目标范围内,所获得的生命年数为69,367。生命年潜在节省的规模应促使人们更严格地遵循与更好生存显著相关的指南和做法。